Brief: Myos Rens Technology Initiates Study To Evaluate Impact Of Fortetropin On Quality Of Life & Activity In Geriatric Dogs
27/02/2019 12:31
Feb 27 (Reuters) - MYOS RENS Technology Inc MYOS.O :
* MYOS RENS TECHNOLOGY ANNOUNCES INITIATION OF A STUDY AT
KANSAS
STATE UNIVERSITY TO EVALUATE THE IMPACT OF FORTETROPIN® ON
QUALITY OF LIFE AND ACTIVITY IN GERIATRIC DOGS
Source text for Eikon: ID:nPn6XvYFKa
Further company coverage: MYOS.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Medavail Holdings
See all newsBrief: Medavail Holdings Approved Reduction In Force Of About 40% Of Current Full-Time Employees
Brief: MedAvail Announces Agreement With New Orleans-Based St. Thomas Community Health Centers For Deployment Of Two M4 Medcenters
Brief: Medavail Announces Agreement With ASP Cares For Deployment Of Ten M4 Medcenters
Brief: MedAvail Announces Agreement With Oak Lawn Pharmacy For Deployment M4 Medcenters
Brief: Medavail Announces 1-For-50 Reverse Stock Split